Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 14, 2024
Pyxis Oncology | DEFA14A: Others
Pyxis Oncology | DEF 14A: Definitive information statements
Pyxis Oncology | S-3: Registration statement for specified transactions by certain issuers
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 March 21, 2024
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 8-K: Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update November 7, 2023
Pyxis Oncology | 8-K/A: Current report (Amendment)
Pyxis Oncology | S-8 POS: S-8 POS
Pyxis Oncology | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Pyxis Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pyxis Oncology | 8-K: Current report
No Data